AVTX
#2622
Avalo Therapeutics, Inc. - Common Stock
13.2 4 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.00%
Variación mensual
-19.42%
Variación en los últimos 6 meses
-2.36%
Cambio anual
-2.58%
Cierres anteriores
13.6 5
Open
13.5 6
Mínimo
13.1 3
Máximo
13.6 9
Financials
2020
Quarterly report, Q1 FY2020
Avalo Therapeutics, Inc. quarterly report, Q1 FY2020
10-Q
Current report, 25 Mar 2020
Avalo Therapeutics, Inc. current report, 25 March 2020
8-K
Current report, 17 Mar 2020
Avalo Therapeutics, Inc. current report, 17 March 2020
8-K
Current report, 11 Mar 2020
Avalo Therapeutics, Inc. current report, 11 March 2020
8-K
Current report, 13 Feb 2020
Avalo Therapeutics, Inc. current report, 13 February 2020
8-K
Current report, 03 Feb 2020
Avalo Therapeutics, Inc. current report, 03 February 2020
8-K
Current report, 31 Jan 2020
Avalo Therapeutics, Inc. current report, 31 January 2020
8-K
2019
Annual report, FY2019
Avalo Therapeutics, Inc. annual report, FY2019
10-K
Current report, 23 Dec 2019
Avalo Therapeutics, Inc. current report, 23 December 2019
8-K
Current report, 09 Dec 2019
Avalo Therapeutics, Inc. current report, 09 December 2019
8-K